New Managed Care Study Results Reported from Yale University School of Medicine (Association of Social Determinants of Health with Utilization of SGLT2 Inhibitors and GLP1 Receptor Agonists: A Systematic Review and Meta-Analysis): Managed Care

This content is restricted to site members. If you are an existing user, please log in. If you are a new user, please register for access